Kimia Farma Persero Tbk Cash Flow Conversion Efficiency

Latest as of June 2026: -0.065x

Kimia Farma Persero Tbk cash flow conversion efficiency. Based on the latest financial reports, Kimia Farma Persero Tbk (KAEF) has a cash flow conversion efficiency ratio of -0.065x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp-180.20 Billion ≈ $-10.56 Million USD) by net assets (Rp2.79 Trillion ≈ $163.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Kimia Farma Persero Tbk (2003–2025)

Cash flow conversion efficiency of Kimia Farma Persero Tbk from 2003 to 2025. This chart illustrates how Kimia Farma Persero Tbk's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Kimia Farma Persero Tbk stock quote for real-time trading data and today's change.

Kimia Farma Persero Tbk Cash Flow Conversion Ratio Explained

Kimia Farma Persero Tbk cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Kimia Farma Persero Tbk Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kimia Farma Persero Tbk ranked by their cash flow conversion efficiency. Also see KAEF market cap overview for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Asuransi Multi Artha Guna Tbk PT
JK:AMAG
0.010x
Jw Life Science Corp
KO:234080
0.077x
Min Aik Technology Co Ltd
TW:3060
-0.028x
Anavex Life Sciences Corp
NASDAQ:AVXL
-0.120x
TCM Group
CO:TCM
0.087x
LifeMD Inc
NASDAQ:LFMD
-0.142x
Honghua Group Limited
F:4HB
0.011x
Sidus Space Inc
NASDAQ:SIDU
-0.018x

Annual Cash Flow Conversion Efficiency for Kimia Farma Persero Tbk (2003–2025)

The table below shows the annual cash flow conversion efficiency of Kimia Farma Persero Tbk from 2003 to 2025. Review Kimia Farma Persero Tbk free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Rp2.51 Trillion
≈ $147.06 Million
Rp236.75 Billion
≈ $13.87 Million
0.094x +110.55%
2024-12-31 Rp3.43 Trillion
≈ $200.91 Million
Rp153.62 Billion
≈ $9.00 Million
0.045x +178.56%
2023-12-31 Rp6.39 Trillion
≈ $374.59 Million
Rp-364.58 Billion
≈ $-21.36 Million
-0.057x -232.05%
2022-12-31 Rp9.34 Trillion
≈ $547.25 Million
Rp403.34 Billion
≈ $23.63 Million
0.043x +239.48%
2021-12-31 Rp7.23 Trillion
≈ $423.76 Million
Rp-223.92 Billion
≈ $-13.12 Million
-0.031x -121.59%
2020-12-31 Rp7.11 Trillion
≈ $416.36 Million
Rp1.02 Trillion
≈ $59.71 Million
0.143x +157.34%
2019-12-31 Rp7.41 Trillion
≈ $434.37 Million
Rp-1.85 Trillion
≈ $-108.63 Million
-0.250x -528.82%
2018-12-31 Rp3.36 Trillion
≈ $196.68 Million
Rp195.75 Billion
≈ $11.47 Million
0.058x +359.68%
2017-12-31 Rp2.57 Trillion
≈ $150.74 Million
Rp32.64 Billion
≈ $1.91 Million
0.013x -86.50%
2016-12-31 Rp2.27 Trillion
≈ $133.10 Million
Rp213.43 Billion
≈ $12.51 Million
0.094x -13.74%
2015-12-31 Rp1.86 Trillion
≈ $109.11 Million
Rp202.84 Billion
≈ $11.89 Million
0.109x -31.09%
2014-12-31 Rp1.81 Trillion
≈ $106.13 Million
Rp286.31 Billion
≈ $16.78 Million
0.158x +1.18%
2013-12-31 Rp1.62 Trillion
≈ $95.18 Million
Rp253.78 Billion
≈ $14.87 Million
0.156x -2.34%
2012-12-31 Rp1.44 Trillion
≈ $84.47 Million
Rp230.61 Billion
≈ $13.51 Million
0.160x +138.80%
2011-12-31 Rp1.25 Trillion
≈ $73.39 Million
Rp83.91 Billion
≈ $4.92 Million
0.067x -47.21%
2010-12-31 Rp1.11 Trillion
≈ $65.28 Million
Rp141.37 Billion
≈ $8.28 Million
0.127x +3.52%
2009-12-31 Rp995.32 Billion
≈ $58.32 Million
Rp122.01 Billion
≈ $7.15 Million
0.123x +504.90%
2008-12-31 Rp947.76 Billion
≈ $55.54 Million
Rp-28.69 Billion
≈ $-1.68 Million
-0.030x -149.52%
2007-12-31 Rp908.03 Billion
≈ $53.21 Million
Rp55.51 Billion
≈ $3.25 Million
0.061x -62.05%
2006-12-31 Rp870.65 Billion
≈ $51.02 Million
Rp140.24 Billion
≈ $8.22 Million
0.161x +344.45%
2005-12-31 Rp844.22 Billion
≈ $49.47 Million
Rp30.60 Billion
≈ $1.79 Million
0.036x -91.31%
2003-12-31 Rp754.46 Billion
≈ $44.21 Million
Rp314.63 Billion
≈ $18.44 Million
0.417x --

About Kimia Farma Persero Tbk

JK:KAEF Indonesia Medical Distribution
Market Cap
$110.25 Million
Rp1.88 Trillion IDR
Market Cap Rank
#18638 Global
#290 in Indonesia
Share Price
Rp338.00
Change (1 day)
-5.59%
52-Week Range
Rp338.00 - Rp715.00
All Time High
Rp6895.27
About

PT Kimia Farma Tbk, together with its subsidiaries, manufactures and sells a range of medicines in Indonesia and internationally. It operates through Manufacture, Distribution, Retail, and Others segments. The company offers drugs in the form of tablets, effervescent tablets, hard and soft capsules, liquids, syrups, oral powders, non-beta-lactam external liquids, beta-lactam tablets and dry syrup… Read more